This patent application appeared to have been abandoned through lack of timely action, but a petition to extend Examination was GRANTED on 17 May. The failure to respond was deemed to be inadvertent.
This is a significant development, imo. The Examiner had contended that combining NOX66 with chemotherapy would have been obvious, but Noxopharm's attorney responded that the claim was for the combination of NOX66 plus sub-therapeutic doses of chemotherapy; and provided proof that the combination was effective. There is no prior art that suggests the use of sub-therapeutic doses of chemo.
Looking good for Allowance, in my view.
- Forums
- ASX - By Stock
- NOX
- Targeted Drug Delivery
Targeted Drug Delivery
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
IGO
IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
MND
Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
Add NOX (ASX) to my watchlist
|
|||||
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.04M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 72463 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.2¢ | 8810 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 72463 | 0.069 |
3 | 22705 | 0.068 |
1 | 1672 | 0.066 |
1 | 15000 | 0.065 |
1 | 15626 | 0.064 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 8810 | 1 |
0.073 | 74991 | 2 |
0.074 | 50000 | 1 |
0.076 | 4999 | 1 |
0.079 | 12000 | 1 |
Last trade - 10.16am 29/07/2024 (20 minute delay) ? |
Featured News
NVA
Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
MND
Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
NOX (ASX) Chart |
Day chart unavailable